Evidence map›Paper›PMID 22573626›Full record

ArticleNeurology2012

Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

D Cella, J-S Lai, C J Nowinski, D Victorson, A Peterman, D Miller, F Bethoux, A Heinemann, S Rubin, J E Cavazos and 14 more

4 registry-linked trialsAbstract read
In one paragraph

Article in Neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 416 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
416citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02795052 narecruitingnot on this mapstarted 2016, after this paper: background citation

Neurologic Bone Marrow Derived Stem Cell Treatment Study

TypeinterventionalSponsorMD Stem CellsRan2016 to 2028Enrolled500ConditionsNeurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases, Neurological DisordersArmsIntravenous and Intranasal BMSC
NCT05319093 terminatednot on this mapstarted 2022, after this paper: background citation

Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients

TypeobservationalSponsorBrigham and Women's HospitalRan2022 to 2024Enrolled26ConditionsFatigue, Multiple SclerosisArmsOzanimod
NCT06867081 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of a Customized Digital Platform to Increase Coordination of Care and Uptake of Evidence-based Practices: a Protocol for a Stepped-wedge Cluster Randomized Trial in Quebec

TypeinterventionalSponsorCentre for Interdisciplinary Research in Rehabilitation of Greater MontrealRan2025 to 2029Enrolled962ConditionsAquired Brain Injury, Traumatic Brain Injuries, Stroke, Cardiovascular DiseasesArmsThe intervention will be the BRILLIANT Platform, an online platform which provides five Modules aimed at increasing coordination of care and direct rehabilitation time
NCT07599475 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Boosting Brain and Balance: A Mobile Dual-Task Intervention for Athletes With Concussion and Mild Traumatic Brain Injury (mTBI)

TypeinterventionalSponsorHyunhwa LeeRan2026 to 2027Enrolled20ConditionsMild Traumatic Brain Injury (mTBI), Sports-related Concussion, Heart Rate Variability (HRV), WalkingArmsHome-Based Mobile Dual-Task Intervention (BraW-Day™)
3 · Its place in the literature

Who cites it

416 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Psychometric analysis of the Neuro-QoL Fatigue in generalized Myasthenia Gravis (gMG) using data from a phase 3 trial.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  18. Trial
  19. Trial
  20. Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial.Movement disorders : official journal of the Movement Disorder Society · 2024
    Trial

356 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

D CellaNorthwestern University Feinberg School of Medicine, Chicago, IL, USA. d-cella@northwestern.edu
J-S Lai
C J Nowinski
D Victorson
A Peterman
D Miller
F Bethoux
A Heinemann
S Rubin
J E Cavazos
A T Reder
R Sufit
T Simuni
G L Holmes
A Siderowf
V Wojna
R Bode
N McKinney
T Podrabsky
K Wortman
S Choi
R Gershon
N Rothrock
C Moy

Funding

Neurologic Emergencies Treatment Trials Network: Clinical Coordinating CenterU01NS056975 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARSAN, WILLIAM G · 2006 to 2015
$40.4M
STEERING COMMITTEEU54MD008149 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI OFILI, ELIZABETH O. · 2012 to 2018
$21.1M
Project IV: "Alpha-Synuclein Strains & Diverse Synucleinopathies"P50NS053488 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2007 to 2017
$20.9M
THE NUTRIGENOMICS OF VITAMIN D METABOLISM IN AFRICAN-AMERICANSU54RR022762 · NCRR · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI NORRIS, KEITH C · 2007 to 2011
$19.6M
Immunopathogenesis of HIV Neurological DisordersU54NS043011 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 2001 to 2011
$14.6M
Role of CNS in Modulation of Pelvic Pain SyndromeU01DK082342 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KLUMPP, DAVID J · 2008 to 2021
$10.5M
PROMIS Technical CenterU54AR057943 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GERSHON, RICHARD · 2009 to 2013
$5.3M
QUALITY OF LIFE EVALUATION IN ONCOLOGYR01CA060068 · NCI · RUSH UNIVERSITY MEDICAL CENTER · PI CELLA, DAVID · 1995 to 2008
$4.8M
Quality of Life for SCI Clinical Trials: Development of the SCI-QOLR01HD054569 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TULSKY, DAVID SCOTT · 2007 to 2011
$3.0M
Reflexology: An Intervention for Advanced Breast CancerR01CA104883 · NCI · MICHIGAN STATE UNIVERSITY · PI WYATT, GWEN KARILYN · 2005 to 2009
$2.3M
Pathophysiology of HIV Dementia in WomenS11NS046278 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI WOJNA, VALERIE · 2004 to 2008
$1.6M
GENORM: Collection of Genotypic Data for the NIH Toolbox Norming SampleRC2AG036498 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GERSHON, RICHARD · 2009 to 2010
$930k
NCI NIH HHS R01 CA060068NCI NIH HHS R01 CA104883NCRR NIH HHS U54 RR022762NHLBI NIH HHS K23 HL085766NIAMS NIH HHS U54 AR057943NIA NIH HHS RC2 AG036498NICHD NIH HHS R01 HD054569NIDDK NIH HHS U01 DK082342NIMHD NIH HHS U54 MD008149NINDS NIH HHS HHSN265200423601CNINDS NIH HHS P50 NS053488NINDS NIH HHS S11 NS046278NINDS NIH HHS U01 NS056975NINDS NIH HHS U54 NS043011
6 · The paper itself

Abstract

objectiveTo address the need for brief, reliable, valid, and standardized quality of life (QOL) assessment applicable across neurologic conditions.

methodsDrawing from larger calibrated item banks, we developed short measures (8-9 items each) of 13 different QOL domains across physical, mental, and social health and evaluated their validity and reliability. Three samples were utilized during short form development: general population (Internet-based, n = 2,113); clinical panel (Internet-based, n = 553); and clinical outpatient (clinic-based, n = 581). All short forms are expressed as T scores with a mean of 50 and SD of 10.

resultsInternal consistency (Cronbach α) of the 13 short forms ranged from 0.85 to 0.97. Correlations between short form and full-length item bank scores ranged from 0.88 to 0.99 (0.82-0.96 after removing common items from banks). Online respondents were asked whether they had any of 19 different chronic health conditions, and whether or not those reported conditions interfered with ability to function normally. All short forms, across physical, mental, and social health, were able to separate people who reported no health condition from those who reported 1-2 or 3 or more. In addition, scores on all 13 domains were worse for people who acknowledged being limited by the health conditions they reported, compared to those who reported conditions but were not limited by them.

conclusionThese 13 brief measures of self-reported QOL are reliable and show preliminary evidence of concurrent validity inasmuch as they differentiate people based upon number of reported health conditions and whether those reported conditions impede normal function.

Indexed as

Health StatusQuality of LifeAgedFemaleHumansInternetMaleMiddle AgedNervous System DiseasesNeurologyOutpatientsReproducibility of ResultsSelf ReportSurveys and Questionnaires

Identifiers

PMID22573626
PMCPMC3369516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.